At this time, there is no proven effective treatment for nonarteritic anterior ischemic optic neuropathy (NAION). Sometimes, corticosteroids may be given to help reduce the inflammation associated with the condition, but the effectiveness of this treatment option is still inconclusive.
Treating the underlying causes of cardiovascular disease, a risk factor for NAION, may help control NAION and prevent further vision loss.
For arteritic AION — the more dangerous form of ION — corticosteroids are given to protect the non-affected eye.
For anyone with vision loss from ischemic optic neuropathy, low vision aids and strategies can be helpful.